XML 27 R17.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Schedule of Net Income (Loss) Per Share

The net income/(loss) per share presented in the condensed statements of operations is based on the following:

Schedule of Net Income (Loss) Per Share

		Three Months ended September 30, 2023				Three Months ended September 30, 2022				Nine months ended September 30,2023				Nine months ended September 30,2022

Net income		$	486,555			$	-			$	1,712,827			$	-
Income earned on Trust Account			(604,781	)			-				(2,178,843	)			-
Accretion of carrying value to redemption value			-				-				(7,737,382	)			-
Net loss including accretion of equity into redemption value		$	(118,226	)		$	-			$	(8,203,398	)		$	-

Schedule of Income (Loss) Basic and Diluted Per Share


		Three months ended September 30, 2023								Nine months ended September 30, 2023								Three months ended September 30, 2022				Nine months ended September 30, 2022
		Redeemable				Non-Redeemable				Redeemable				Non-Redeemable				Non-Redeemable				Non-Redeemable
Particulars		Shares				Shares				Shares				Shares				Shares				Shares
Basic and diluted net income/(loss) per share:
Numerators:
Allocation of net loss including accretion of temporary equity			(90,297	)			(27,929	)			(6,249,095	)			(1,954,303	)			—				—
Income earned on Trust Account			604,781				—				2,178,843				—				—				—
Accretion of temporary equity to redemption value			—				—				7,737,382				—				—				—
Allocation of net income/(loss)			514,484				(27,929	)			3,667,130				(1,954,303	)			—				—

Denominators:
Weighted-average shares outstanding			6,900,000				2,134,200				6,807,692				2,128,995				1,725,000				1,725,000
Basic and diluted net income/(loss) per share			0.07				(0.01	)			0.54				(0.92	)			—				—

Schedule of Subject to Possible Redemption

At September 30, 2023, the ordinary shares reflected in the condensed balance sheets are reconciled in the following table:

Gross proceeds		$	69,000,000
Less:
Proceeds allocated to Public Rights			(621,000	)
Proceeds allocated to Public Warrants			(1,104,000	)
Allocation of offering costs related to redeemable shares			(4,770,382	)
Plus:
Accretion of carrying value to redemption value			7,737,382
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account)			2,178,843
Ordinary shares subject to possible redemption		$	72,420,843

Tabular disclosure of the nature and terms of the financial instruments and the rights and obligations embodied in those instruments, information about settlement alternatives, if any, in the contract and identification of the entity that controls the settlement alternatives including: a. The amount that would be paid, or the number of shares that would be issued and their fair value, determined under the conditions specified in the contract if the settlement were to occur at the reporting date b. How changes in the fair value of the issuer's equity shares would affect those settlement amounts (for example, "the issuer is obligated to issue an additional x shares or pay an additional y dollars in cash for each $1 decrease in the fair value of one share") c. The maximum amount that the issuer could be required to pay to redeem the instrument by physical settlement, if applicable d. The maximum number of shares that could be required to be issued, if applicable e. That a contract does not limit the amount that the issuer could be required to pay or the number of shares that the issuer could be required to issue, if applicable f. For a forward contract or an option indexed to the issuer's equity shares, the forward price or option strike price, the number of issuer's shares to which the contract is indexed, and the settlement date or dates of the contract, as applicable. g. The components of the liability that would otherwise be related to shareholders' interest and other comprehensive income (if any) subject to the redemption feature (for example, par value and other paid in amounts of mandatorily redeemable instruments are disclosed separately from the amount of retained earnings or accumulated deficit).

+ References + Details